Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
1-[3-[(2S,5S,8S,11S,14S,17S,20S,23S,26S)-5,8,11,14-tetrakis(3-guanidinopropyl)-17,20,23,26-tetrakis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine
ID: ALA5275124
Chembl Id: CHEMBL5275124
Max Phase: Preclinical
Molecular Formula: C74H100N28O9
Molecular Weight: 1525.80
Associated Items: